DICE Therapeutics Inc.

DICE | NASDAQ

Price Alert Chart Builder DCF Calculator

$47.55

+$0.03 (+0.06%)

Aug 08, 2023, 04:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.27B

Enterprise Value $1.75B

Beta 0.00

Average Volume N/A

Shares Outstanding (Diluted) 47.31M

Shares Change YoY 26.62%

Institutional Ownership N/A

Exchange N/A

ISIN N/A

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) 2.5%

1Y CAGR (ann.) 143.0%

5Y CAGR (ann.) N/A

All-Time CAGR 14.1%

Valuation

PE Ratio -21.71

Forward PE N/A

PEG Ratio -0.64

Forward PEG -0.64

PS Ratio N/A

Forward PS N/A

PB Ratio 4.37

P/FCF Ratio -26.04

P/Adj. FCF Ratio -21.75

P/OCF Ratio -29.17

EV/Sales N/A

EV/EBIT -23.46

EV/EBITDA -17.14

EV/FCF -20.12

Earnings Yield -4.6%

FCF Yield -3.8%

Adj. FCF Yield -4.6%

Financial Health

Net Cash $515.8M

Total Debt $12.58M

Cash & Short-Term Investments $528.38M

Total Assets $550.67M

Current Ratio 38.14

Quick Ratio 38.14

Debt / Equity Ratio -0.07

Debt / EBITDA -0.12

Debt / FCF -0.14

OCF / Debt -6.70

Interest Coverage -129.93

Altman Z-Score 43.24

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -19.7%

Returns

Return on Assets -13.8%

Return on Equity 56.1%

Return on Invested Capital -14.8%

Return on Capital Employed -15.2%

Return on Tangible Assets -13.8%

Historical Growth (CAGR)

Revenue CAGR 3Y -65.1%

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -22.5%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -53.9%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 10

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date May 9, 2024

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $60

Price Target Upside 26.2%

Cash Flow

Operating Cash Flow $-84.23M

Free Cash Flow $-87.22M

Adj. Free Cash Flow $-104.42M

FCF Per Share -$1.69

OCF Per Share -$1.63

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-118.69M

EBITDA $-102.4M

Net Income $-97.08M

EPS (Diluted) -$2.19

Revenue / Employee N/A

Profit / Employee N/A

Employees N/A